Related Experiment Video
Updated: May 24, 2026
09:25
Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
Epigenetics in ovarian cancer
1Department of Reproductive Medicine and Gynaecology, Gynaecological Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Methods in Molecular Biology (Clifton, N.J.)
|February 24, 2012
Summary
Epigenetic changes like DNA methylation are key in ovarian cancer progression and drug resistance. These modifications, detectable in serum, offer potential for early diagnosis and are targets for new epigenetic therapies.
Area of Science:
- Gynecologic Oncology
- Cancer Epigenetics
- Molecular Oncology
Background:
- Ovarian cancer is a lethal gynecological malignancy with late diagnosis and frequent drug resistance.
- Current diagnostic and treatment strategies face challenges due to disease heterogeneity and acquired resistance.
- Epigenetic alterations are increasingly recognized as critical drivers in ovarian cancer development and progression.
Purpose of the Study:
- To describe epigenetic changes in ovarian cancer.
- To highlight the potential of epigenetic modifications as biomarkers for diagnosis, prognosis, and prediction.
- To discuss the therapeutic implications of targeting epigenetic aberrations in ovarian cancer.
Main Methods:
- Review of current literature on epigenetic modifications in ovarian cancer.
- Identification of key epigenetic alterations such as CpG island methylation and histone modifications.
- Analysis of the role of epigenetic changes in disease subtypes, serum detection, and drug resistance.
Main Results:
- Epigenetic aberrations, including DNA methylation and histone modifications, are prevalent in ovarian cancer.
- These epigenetic changes correlate with specific disease subtypes and are detectable in patient serum.
- Epigenetic modifications show promise as diagnostic, prognostic, and predictive biomarkers, requiring further validation.
Conclusions:
- Epigenetic modifications are fundamental to ovarian cancer pathogenesis and drug resistance.
- Epigenetic biomarkers offer potential for improved early detection and patient stratification.
- The reversible nature of epigenetic changes makes them attractive targets for novel epigenetic therapies, as supported by preclinical evidence.
More Related Videos
12:42Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
02:30Genomic Imprinting and Inheritance
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
01:21Nondisjunction
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...